130 related articles for article (PubMed ID: 25223804)
1. A risk evaluation model of cervical cancer based on etiology and human leukocyte antigen allele susceptibility.
Hu B; Tao N; Zeng F; Zhao M; Qiu L; Chen W; Tan Y; Wei Y; Wu X; Wu X
Int J Infect Dis; 2014 Nov; 28():8-12. PubMed ID: 25223804
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.
Maciag PC; Schlecht NF; Souza PS; Franco EL; Villa LL; Petzl-Erler ML
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1183-91. PubMed ID: 11097225
[TBL] [Abstract][Full Text] [Related]
4. HLA DRB allele polymorphisms and risk of cervical cancer associated with human papillomavirus infection: a population study in China.
Zhao M; Qiu L; Tao N; Zhang L; Wu X; She Q; Zeng F; Wang Y; Wei S; Wu X
Eur J Gynaecol Oncol; 2013; 34(1):54-9. PubMed ID: 23590002
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
[TBL] [Abstract][Full Text] [Related]
6. Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women.
Gokhale P; Kerkar S; Tongaonkar H; Chaudhari H; Warke H; Salvi V; Mania-Pramanik J
Indian J Med Res; 2014 Nov; 140 Suppl(Suppl 1):S36-43. PubMed ID: 25673541
[TBL] [Abstract][Full Text] [Related]
7. HLA-DRB1*1602 allele is positively associated with HPV cervical infection in Bolivian Andean women.
Cervantes J; Lema C; Valentina Hurtado L; Andrade R; Hurtado Gomez L; Torrico L; Zegarra L; Quiroga G; Asturizaga D; Dulon A; Prada R; Panoso W; Yashiki S; Fujiyoshi T; Sonoda S
Hum Immunol; 2003 Sep; 64(9):890-5. PubMed ID: 12941545
[TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigen class II and cervical cancer risk: a population-based study.
Madeleine MM; Brumback B; Cushing-Haugen KL; Schwartz SM; Daling JR; Smith AG; Nelson JL; Porter P; Shera KA; McDougall JK; Galloway DA
J Infect Dis; 2002 Dec; 186(11):1565-74. PubMed ID: 12447731
[TBL] [Abstract][Full Text] [Related]
9. HLA Class II alleles and association with HPV Infection prevalence in high-risk HPV-positive Han women in southern China.
Zheng Z; He Q; An L; Li D; Wang N; Wang L; Sun Q; Wang J; Xiao P; Du K; Li B
Infect Dis Now; 2021 Feb; 51(1):67-70. PubMed ID: 33007402
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigens I and II haplotypes associated with human papillomavirus 16-positive invasive cervical cancer in Mexican women.
Hernández-Hernández DM; Cerda-Flores RM; Juárez-Cedillo T; Granados-Arriola J; Vargas-Alarcón G; Apresa-García T; Alvarado-Cabrero I; García-Carrancá A; Salcedo-Vargas M; Mohar-Betancourt A
Int J Gynecol Cancer; 2009 Aug; 19(6):1099-106. PubMed ID: 19820376
[TBL] [Abstract][Full Text] [Related]
11. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
[TBL] [Abstract][Full Text] [Related]
12. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix.
Sastre-Garau X; Loste MN; Vincent-Salomon A; Favre M; Mouret E; de la Rochefordiere A; Durand JC; Tartour E; Lepage V; Charron D
Int J Cancer; 1996 Jun; 69(3):159-64. PubMed ID: 8682580
[TBL] [Abstract][Full Text] [Related]
13. HLA-B*07 is a high risk allele for familial cervical cancer.
Qiu X; Zhang F; Chen D; Azad AK; Zhang L; Yuan Y; Jiang Z; Liu W; Tan Y; Tao N
Asian Pac J Cancer Prev; 2011; 12(10):2597-600. PubMed ID: 22320938
[TBL] [Abstract][Full Text] [Related]
14. Classical HLA alleles are associated with prevalent and persistent cervical high-risk HPV infection in African women.
Adebamowo SN; Adeyemo AA;
Hum Immunol; 2019 Sep; 80(9):723-730. PubMed ID: 31072753
[TBL] [Abstract][Full Text] [Related]
15. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri.
Beskow AH; Gyllensten UB
Int J Cancer; 2002 Oct; 101(6):526-31. PubMed ID: 12237892
[TBL] [Abstract][Full Text] [Related]
16. Human Leukocyte Antigen Class I and Class II Polymorphisms and Serum Cytokine Profiles in Cervical Cancer.
Bahls L; Yamakawa R; Zanão K; Alfieri D; Flauzino T; Delongui F; de Abreu A; Souza R; Gimenes F; Reiche E; Borelli S; Consolaro M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858203
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.
Castro FA; Haimila K; Sareneva I; Schmitt M; Lorenzo J; Kunkel N; Kumar R; Försti A; Kjellberg L; Hallmans G; Lehtinen M; Hemminki K; Pawlita M
Int J Cancer; 2009 Oct; 125(8):1851-8. PubMed ID: 19585495
[TBL] [Abstract][Full Text] [Related]
18. From HPV Infection to Lesion Progression: The Role of HLA Alleles and Host Immunity.
Paaso A; Jaakola A; Syrjänen S; Louvanto K
Acta Cytol; 2019; 63(2):148-158. PubMed ID: 30783048
[TBL] [Abstract][Full Text] [Related]
19. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women.
Cuzick J; Terry G; Ho L; Monaghan J; Lopes A; Clarkson P; Duncan I
Br J Cancer; 2000 Apr; 82(7):1348-52. PubMed ID: 10755413
[TBL] [Abstract][Full Text] [Related]
20. HLA-DQB1 and cervical cancer in Venezuelan women.
Dao DD; Sierra-Torres CH; Robazetti SC; de Gomez MN; König R; Lema C; Lester LJ; Au WW; Tyring SK
Gynecol Oncol; 2005 Feb; 96(2):349-54. PubMed ID: 15661220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
